Technology | November 21, 2013

AliveCor Transforms Heart Monitor Into eHealth Service

Expert Analysis, Physician Portal Simplify Monitoring Heart Health

cardiac diagnostics software mobile devices ecg monitoring services alivecor
November 21, 2013 — AliveCor Inc. launched a mobile heart health service, offering expert reviews of electrocardiograms (ECGs) recorded through their smartphone application. Patients can share these expert reviews and their ECGs with their physicians. Physicians in turn can manage their patients through AliveCor’s website using their PC or tablet.
 
Expert reviews of ECGs are available through AliveInsights within the AliveECG app. Patients’ and physicians’ smartphones can receive technical reviews performed by a U.S.-based cardiac technicia. They can also receive more in-depth clinical reviews from a U.S. Board-Certified cardiologist for a minimal fee. This around-the-clock resource offers peace of mind to patients.
 
“AliveCor’s new integrated mobile health service offers unprecedented benefits to both patients and physicians,” said Ronald Karlsberg, M.D., Cedars Sinai Heart Institute, Cardiovascular Medical Group of Southern California and clinical professor of medicine, David Geffen School of Medicine, University of California, Los Angeles. “This eHealth service makes it easier for physicians to manage the heart condition of their patients wherever they and their patients are. Just as the introduction of thermometers and blood pressure cuffs in the past helped patients to monitor their health, now the ability to record one’s own electrocardiogram — and get an interpretation almost instantly — empowers the 21st century patient to take charge of their heart health.”
 
The AliveCor Heart Monitor is the only U.S. Food and Drug Administration (FDA)-cleared mobile ECG recorder that supports both iPhone and Android compatible smartphones. It records, displays, annotates, stores and transfers single-channel electrocardiogram (ECG) rhythms wirelessly using the free AliveECG app. With secure storage in the Cloud, patients can access their data confidentially anytime, anywhere and can grant access to their physician. The Heart Monitor is available for purchase in the United States by medical professionals and patients with prescriptions.
 
For more information: www.alivecor.com

Related Content

Insomnia Tied to Higher Risk of Heart Disease and Stroke

Image courtesy of the American Heart Association

News | Cardiac Diagnostics | August 19, 2019
People suffering from insomnia may have an increased risk of coronary artery disease, heart failure and stroke,...
Evolutionary Gene Loss May Help Explain Human Predisposition to Heart Attacks
News | Cardiac Diagnostics | July 29, 2019
The loss of a single gene two to three million years ago in our ancestors may have resulted in a heightened risk of...
U.S. Soldiers Have Worse Heart Health Than Civilians
News | Cardiac Diagnostics | June 06, 2019
Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the civilian...
Late Dinner and No Breakfast Worsens Outcomes After Heart Attack
News | Cardiac Diagnostics | May 23, 2019
People who skip breakfast and eat dinner near bedtime have worse outcomes after a heart attack, according to research...
HRS Releases New Expert Consensus Statement on Arrhythmogenic Cardiomyopathy
News | Cardiac Diagnostics | May 14, 2019
The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement with guidance on the evaluation and...
New Best Practices Help Manage Heart Attack Patients Without Significant Signs
News | Cardiac Diagnostics | April 15, 2019
For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices...
The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes.

The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes. 

Feature | Cardiac Diagnostics | March 22, 2019 | Linda C. Rogers, Ph.D.
Troponins are a family of proteins found in skeletal and heart (cardiac) muscle fibers that produce muscular contract
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics | March 18, 2019
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy...
AHA Statement Warns Hookah Smoking May Harm the Heart
News | Cardiac Diagnostics | March 08, 2019
Smoking tobacco in waterpipes, more commonly known as hookahs, results in inhaling toxic chemicals, often at levels...
Overlay Init